Technology

Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

November 12, 2026 Emily Mullin Wired
Synchron Pauses Trials of Its Brain Implant Due to Performance Issues

After its latest device failed to perform, brain-computer interface startup Synchon halted clinical trials. The company says it will upgrade the implant’s hardware and is at work on a new device.

Read Full Article

This article was originally published on Wired. Click the button above to read the complete article.

Related Articles

Objective Corporation (ASX:OCL) Shares in Focus: Why Is the ASX 300 Stock Drawing Attention? - Kalkine Media

Objective Corporation (ASX:OCL) Shares in Focus: Why Is the ASX 300 Stock Drawing Attention? - Kalkine Media
WiseTech Global (ASX:WTC) Shares Climb: Why Is the ASX 100 Stock Higher? - Kalkine Media

WiseTech Global (ASX:WTC) Shares Climb: Why Is the ASX 100 Stock Higher? - Kalkine Media
An opportunity for New Mexico’s children is no betrayal

An opportunity for New Mexico’s children is no betrayal
If an AI Bubble Triggers a Bear Market, History Says This Is the Best Move Investors Can Make

If an AI Bubble Triggers a Bear Market, History Says This Is the Best Move Investors Can Make
Apex Joins Hedera Council as Fund Servicing Moves Deeper Into Tokenization

Apex Joins Hedera Council as Fund Servicing Moves Deeper Into Tokenization
Jensen Huang is gone. Nvidia’s controls still need explaining

Jensen Huang is gone. Nvidia’s controls still need explaining